Chappel Group is a clinical research site located in Kissimmee, Florida, United States 34744.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Chappel Group has participated in 1 clinical trials.
Therapeutic areas: Covid19.
Sponsors: LumiraDx UK Limited.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Chappel Group has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Chappel Group has 1 clinical trials on record. Their work covers Covid19.
Chappel Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.